Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

    Virus Research, pp. 53-62, 2018.

    Cited by: 18|Bibtex|Views2|

    Abstract:

    Abstract The development and clinical implementation of direct-acting antivirals (DAAs) has revolutionized the treatment of chronic hepatitis C. Infection with any hepatitis C virus (HCV) genotype can now be eliminated in more than 95% of patients with short courses of all-oral, well-tolerated drugs, even in those with advanced liver di...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments